Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (MB2865) |
- |
- |
>64 - ? |
Ascosteroside |
803 |
Staphylococcus aureus (MB2865) |
- |
- |
64 - ? |
Caspofungin acetate (Cancidas, L-743872, MK-0991) |
803 |
Staphylococcus aureus (MB2865) |
- |
- |
>64 - ? |
Enfumafungin |
803 |
Staphylococcus aureus (MB2865) |
- |
- |
? - 32 |
Caspofungin (MK-0991) |
1020 |
Staphylococcus aureus (MB2865) |
- |
- |
? - >32 |
Phomafungin |
1020 |
Staphylococcus aureus (MB5393) |
- |
- |
0.125 - ? |
Philipimycin |
1270 |
Staphylococcus aureus (MB5832) |
- |
- |
>32 - ? |
Philipimycin |
1270 |
Staphylococcus aureus (MCJ-25 + methicillin-resistant) |
- |
- |
0.5 - ? |
Telavancin (TD-6424, Vibativ) |
269 |
Staphylococcus aureus (MCJ-25 + methicillin-resistant) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |
Staphylococcus aureus (MCJ-25 + methicillin-resistant) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
269 |
Staphylococcus aureus (MCJ-25 + methicillin-resistant) |
- |
- |
32 - ? |
Nafcillin (Unipen, Nafcil) |
269 |
Staphylococcus aureus (MDRSA) |
- |
- |
1 - ? |
PC190723 |
253 |
Staphylococcus aureus (MED-415 + methicillin-susceptible) |
- |
- |
0.25 - ? |
Nafcillin (Unipen, Nafcil) |
269 |
Staphylococcus aureus (MED-415 + methicillin-susceptible) |
- |
- |
0.5 - ? |
Telavancin (TD-6424, Vibativ) |
269 |
Staphylococcus aureus (MED-415 + methicillin-susceptible) |
- |
- |
1 - ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |
Staphylococcus aureus (MED-415 + methicillin-susceptible) |
- |
- |
4 - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
269 |
Staphylococcus aureus (Meth SA3) |
- |
- |
0.06 - ? |
Retapamulin |
120 |
Staphylococcus aureus (Meth SA3) |
- |
- |
0.06 - ? |
Retapamulin |
120 |
Staphylococcus aureus (Meth SA3) |
- |
- |
0.12 - ? |
Mupirocin (Bactroban) |
120 |
Staphylococcus aureus (Meth SA7) |
- |
- |
0.06 - ? |
Retapamulin |
120 |
Staphylococcus aureus (Meth SA7) |
- |
- |
0.06 - ? |
Retapamulin |
120 |
Staphylococcus aureus (Meth SA7) |
- |
- |
0.12 - ? |
Mupirocin (Bactroban) |
120 |
Staphylococcus aureus (methicillin-resistant + 275/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |
Staphylococcus aureus (methicillin-resistant + 277/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |
Staphylococcus aureus (methicillin-resistant + 306/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |
Staphylococcus aureus (methicillin-resistant + 307/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |
Staphylococcus aureus (methicillin-resistant + 309/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |
Staphylococcus aureus (methicillin-resistant + 329/08) |
- |
- |
10 - ? |
Ag (nanoparticles suspension H) |
936 |